drugset / Trial / NCT02961660
A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir
Non-randomizedParallel-groupOpen-labelOther
Summary
The main purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of odalasvir (ODV) in participants with severe renal impairment and compare with the PK in matched participants with normal renal function.
Timeline
- Start
- 2016-11-09
- Primary completion
- 2018-04-09
- Completion
- 2018-04-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Odalasvir | Small molecule | 25 mg | Oral |